‌

US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor

Patent 12076322 was granted and assigned to Plexxikon Inc. on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Wayne Spevak0

Ying Zhang0

Chao Zhang0

Hanna Cho0

Songyuan Shi0

Jiazhong Zhang0

Guoxian Wu0

Prabha N. Ibrahim0

...

Date of Patent

September 3, 2024

0

Patent Application Number

178959720

Date Filed

August 25, 2022

0

Patent Citations

US Patent 7348338 PPAR active compounds

0

US Patent 7361763 Pyrrolo-pyridine kinase modulators

0

US Patent 7361764 Pyrrolo-pyridine kinase modulators

0

US Patent 7452993 Fused ring heterocycle kinase modulators

0

US Patent 7476746 PPAR active compounds

0

US Patent 7491831 PPAR active compounds

0

US Patent 7498342 Compounds modulating c-kit activity

0

US Patent 7504509 Compounds and methods for development of Ret modulators

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

Patent abstract

Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.